Belcher's Withheld Prior Art Again Dooms Drug Patent Suit
The Federal Circuit on Wednesday upheld a decision out of Delaware that a Belcher Pharmaceuticals epinephrine patent can't be enforced because prior art that undercut its novelty was intentionally left out...To view the full article, register now.
Already a subscriber? Click here to view full article